title: Arabilin overcomes resistance to AR-targeted therapy.
authors.affiliation: Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Yokohama, Japan.
authors.forename: Takahiro
authors.initials: T
authors.lastname: Fujimaki
authors.affiliation: Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Yokohama, Japan.
authors.forename: Shun
authors.initials: S
authors.lastname: Saito
authors.affiliation: Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Yokohama, Japan.
authors.forename: Masaya
authors.initials: M
authors.lastname: Imoto
mesh_terms: D059002:Androgen Receptor Antagonists / Q000494:pharmacology*; D045744:Cell Line, Tumor; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011753:Pyrones / Q000494:pharmacology*
chemical_list: D059002:Androgen Receptor Antagonists; D011753:Pyrones; C553367:arabilin